Influenza and other respiratory viruses · 2024

Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен

Обработка статьи · этапы, ошибки и управление

Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Rose Angela M C, Pozo Francisco, Martínez-Baz Iván, Mazagatos Clara, Bossuyt Nathalie, Cauchi John Paul, Petrović Goranka, Loghin Isabela I, Vaikutyte Roberta, Buda Silke, Machado Ausenda, Duffy Róisín, Oroszi Beatrix, Howard Jennifer, Echeverria Aitziber, Andreu Cristina, Barbezange Cyril, Džiugytė Aušra, Nonković Diana, Popescu Corneliu-Petru, Majauskaite Fausta, Tolksdorf Kristin, Gomez Verónica, Domegan Lisa, Horváth Judit Krisztina, Castilla Jesús, García Miriam, Demuyser Thomas, Borg Maria-Louise, Tabain Irena, Lazar Mihaela, Kubiliute Ieva, Dürrwald Ralf, Guiomar Raquel, O'Donnell Joan, Kristóf Katalin, Nicolay Nathalie, Bacci Sabrina, Kissling Esther, VEBIS SARI VE network team, Belgium SARI Surveillance Network (BelsariNet)

Аннотация

We conducted a multicentre hospital-based test-negative case-control study to measure vaccine effectiveness (VE) against PCR-confirmed influenza in adult patients with severe acute respiratory infection (SARI) during the 2022/2023 influenza season in Europe. Among 5547 SARI patients ≥18 years, 2963 (53%) were vaccinated against influenza. Overall VE against influenza A(H1N1)pdm09 was 11% (95% CI: -23-36); 20% (95% CI: -4-39) against A(H3N2) and 56% (95% CI: 22-75) against B. During the 2022/2023 season, while VE against hospitalisation with influenza B was >55%, it was ≤20% for influenza A subtypes. While influenza vaccination should be a priority for future seasons, improved vaccines against influenza are needed.

Предметные рубрики MeSH

Adult Humans Influenza, Human Seasons Influenza A Virus, H1N1 Subtype Influenza A Virus, H3N2 Subtype Case-Control Studies Vaccine Efficacy Influenza Vaccines Europe Hospitalization Hospitals Pneumonia Vaccination

Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.

Ошибки и ограничения

Аннотация

Предметные рубрики MeSH